Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Clinical trial NCT04169711 · COMPLETED
Trial details
- NCT number
- NCT04169711
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2022-01-24
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.